investorscraft@gmail.com

Stock Analysis & ValuationLite Strategy, Inc. (LITS)

Previous Close
$1.21
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)55.184460
Intrinsic value (DCF)62.815091
Graham-Dodd Methodn/a
Graham Formula107.968822

Company Information

9920 Pacific Heights Blvd.
San Diego, CA 92121
United States
Phone: 858 369 7100
Industry: Biotechnology
Sector: Healthcare
CEO: Anne Frese
Full Time Employees: 4

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

HomeMenuAccount